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Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A) is important for maintenance of latency in
infected B lymphocytes. Through its immunoreceptor tyrosine-based activation motif (ITAM) and PY motifs,
LMP2A is able to block B-cell receptor (BCR) signaling, bind BCR-associated kinases, and manipulate the
turnover of itself and these kinases via a PY-mediated interaction with the Nedd4 family of ubiquitin ligases.
In epithelial cells, LMP2A has been shown to activate the phosphatidylinositol 3-OH kinase/Akt and -catenin
signaling pathways. In the present study, the biological consequences of LMP2A expression in the normal
human foreskin keratinocyte (HFK) cell line were investigated and the importance of the ITAM and PY motifs
for LMP2A signaling effects in HFK cells was ascertained. The ITAM was essential for the activation of Akt
by LMP2A in HFK cells, while both the ITAM and PY motifs contributed to LMP2A-mediated accumulation
and nuclear translocation of the oncoprotein -catenin. LMP2A inhibited induction of differentiation in an
assay conducted with semisolid methylcellulose medium, and the PY motifs were critical for this inhibition.
LMP2A is expressed in the EBV-associated epithelial malignancies nasopharyngeal carcinoma and gastric
carcinoma, and these data indicate that LMP2A affects cellular processes that likely contribute to
carcinogenesis.
The Epstein-Barr virus (EBV) is a very successful human
herpesvirus that has infected more than 90% of the world’s
adult population (16). The virus is capable of both lytic and
latent forms of infection, and the virus is able to persist
throughout the life of the host via establishment of latency.
Although most EBV infections are asymptomatic, disease
arises in a subset of infected individuals, especially in the im-
munocompromised population. EBV infection is associated
with a variety of malignancies, including Hodgkin lymphoma,
endemic Burkitt’s lymphoma, gastric carcinoma, and nasopha-
ryngeal carcinoma (27). These cancers are characterized by the
proliferation of monoclonal EBV-infected cells, and viral ex-
pression in these cells is limited to a subset of latent genes (16,
26, 27). In EBV-associated cancers, EBV nuclear antigen 1 and
other EBV nuclear antigen proteins, 2, 3A, 3B, 3C, and LP, as
well as latent membrane protein 1 (LMP1), LMP2A, and
LMP2B, may be expressed in addition to a series of transcripts
from the BamHI-A region of the EBV genome and EBV-
encoded RNAs (16).
LMP2A is expressed in most EBV-associated tumors, in-
cluding Hodgkin lymphoma, nasopharyngeal carcinoma, and
gastric carcinoma (4, 5, 24, 32). In infected B lymphocytes,
LMP2A functions to maintain viral latency by blocking B-cell
receptor (BCR) activation and signaling, which would other-
wise reactivate the virus to enter the lytic cycle (19–22). Fur-
thermore, experiments with transgenic mice expressing
LMP2A under the control of the E enhancer and promoter
targeting expression to the B-cell lineage revealed that LMP2A
sends survival signals and allows B cells to bypass developmen-
tal checkpoints and escape the bone marrow to colonize pe-
ripheral lymphoid organs (6, 7, 18). Critical for these functions
is the immunoreceptor tyrosine-based activation motif (ITAM)
located in the cytoplasmic amino (N) terminus of LMP2A.
Through its ITAM, LMP2A activates phosphatidylinositol
3-OH kinase (PI3K)/Akt signaling in B lymphocytes and as-
sociates with the BCR signaling effector Syk kinase (9, 31). The
LMP2A N terminus also contains two proline-rich motifs
known as PY motifs that enable it to interact with members of
the Nedd4 family of ubiquitin ligases in B cells (13, 14, 35).
Through these interactions, LMP2A manipulates the turnover
of itself and other binding partners such as Lyn kinase and
possibly Syk.
Because of a lack of expression of the BCR and associated
kinases within epithelial cells, LMP2A signaling in epithelial
cells likely has different effects than in B cells. However, one
pathway that is similarly activated by LMP2A in both epithelial
and B cells is the PI3K/Akt pathway (23, 28, 31). This pathway
has prominent roles in the activation of cell proliferation, mi-
gration, and survival; therefore, activation of the PI3K/Akt
pathway could confer a growth advantage to cells expressing
LMP2A (3, 11, 34). In addition to activation of PI3K/Akt, our
laboratory has recently shown that LMP2A is able to activate
-catenin signaling in human foreskin keratinocyte (HFK)
cells, a normal epithelial cell line derived from primary HFK
cells immortalized via transduction with the catalytic subunit of
telomerase (23). LMP2A signaling in HFK cells leads to cyto-
solic accumulation of the -catenin oncoprotein and PI3K-
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dependent nuclear translocation of -catenin. In the nucleus,
-catenin interacts with members of the T-cell factor/lymphoid
enhancer factor family of transcription factors to activate ex-
pression of genes such as c-myc and CCND1 (cyclin D1), which
could lead to enhancement of cell cycle progression and cell
proliferation (10, 12, 25, 29, 33, 36). Therefore, activation of
-catenin signaling provides another mechanism by which
LMP2A might stimulate cell growth and contribute to EBV-
associated oncogenesis.
Previous studies with the spontaneously immortalized hu-
man epithelial cell line HaCaT suggest that LMP2A has on-
cogenic capacity. HaCaT cells stably expressing LMP2A were
able to form colonies in soft agar in a PI3K-dependent manner
and formed aggressive, poorly differentiated tumors in nude
mice (28). Furthermore, when they were grown in organotypic
raft cultures, LMP2A expression in HaCaT cells led to inhibi-
tion of epithelial cell differentiation, denoted by a lack of
involucrin induction (28).
The goals of the present study were to further characterize
the biological consequences of LMP2A expression in the nor-
mal HFK cell line and to ascertain the importance of the
ITAM and PY motifs of LMP2A for its signaling effects in
HFK cells. The LMP2A ITAM was required for its activation
of Akt in these cells. However, both the PY motifs and the
ITAM were found to be important for the effects of LMP2A on
-catenin accumulation and nuclear translocation. Further-
more, LMP2A inhibited epithelial cell differentiation in meth-
ylcellulose-based differentiation assays, and the PY motifs
were essential for this effect. These data reveal that the ability
of LMP2A to interact with ubiquitin ligases is critical to its
effects on -catenin and to the inhibition of epithelial cell
differentiation.
MATERIALS AND METHODS
Cell lines and materials. HFK cells (8) were maintained in keratinocyte
serum-free medium (K-SFM; Gibco-Invitrogen, Carlsbad, Calif.) supplemented
with 0.2 ng of epidermal growth factor (EGF) per ml, 30 g of bovine pituitary
extract (BPE) per ml, and 1% antibiotic-antimycotic solution (Gibco) at 37°C in
5% CO2. For stable cell lines, 0.5 g of puromycin (Sigma-Aldrich, St. Louis,
Mo.) per ml was added to the K-SFM for selection and maintenance of expres-
sion. Stable cell lines were generated by transduction with recombinant retrovi-
ruses expressing the pBabe vector or the pBabe vector subcloned with hemag-
glutinin (HA)-tagged LMP2A, LMP2A ITAM, or LMP2A PY as previously
described (28), and pools were selected in 0.5 g of puromycin per ml. The
LMP2A ITAM is composed of Tyr74 and Tyr85, and the LMP2A ITAM
mutant protein contains a deletion of residues 80 to 112 of the LMP2A N
terminus with mutation of Tyr74 to Ala. The LMP2A N terminus also has two
PY (PPPPY) motifs responsible for the interaction of LMP2A with members of
the Nedd4 family of ubiquitin ligases in B cells. The LMP2A PY mutant protein
has Pro-to-Ala mutations in the central prolines in each PY motif to abolish this
interaction, and this construct was a kind gift from M. Ikeda and R. Longnecker
(13).
Cells were treated with the PI3K inhibitor LY294002 (LY) (Calbiochem no.
440202; EMD Biosciences, Inc., San Diego, Calif.) at 25 M or the Akt inhibitor
1L-6-hydroxymethyl-chiro-inositol 2[(R)-2-O-methyl-3-O-octadecylcarbonate]
(Calbiochem no. 124005) at 10 M for approximately 24 h. Inhibitors were
solubilized in dimethyl sulfoxide (DMSO; Sigma) as a vehicle control.
Methylcellulose differentiation assays. Methylcellulose medium (1.6%) was
prepared by adding half of the total volume of K-SFM to autoclaved methylcel-
lulose (4,000 cps; Sigma-Aldrich), heating the mixture to 60°C for 20 min, and
then adding the remainder of the K-SFM. At this time, supplements such as 30
g of BPE per ml, 0.2 ng of EGF per ml, 0.5 g of puromycin per ml, and 1%
antibiotic-antimycotic solution were added. Methylcellulose medium was stirred
overnight at 4°C. To set up the assay, 30 ml of methylcellulose medium was
added to 100-mm-diameter sterile petri dishes. HFK cells stably expressing the
pBabe vector, LMP2A, LMP2A ITAM, and LMP2A PY were trypsinized and
counted, and 2  106 to 4  106 cells in 1 ml of K-SFM were added dropwise to
the methylcellulose medium plated in the petri dishes. With the end of a pipette
tip, the cells were stirred throughout the medium to ensure distribution and
incubated at 37°C with 5% CO2 for 1 to 2 days. As a control, an equal number
of cells were plated in a regular 100-mm-diameter tissue culture plate with a total
volume of 10 ml of regular K-SFM (30 g of BPE per ml, 0.2 ng of EGF per ml,
0.5 g of puromycin per ml, and 1% antibiotic-antimycotic solution) without
methylcellulose.
After the designated time periods, cells were harvested. To harvest cells from
the methylcellulose medium, medium with cells was scraped into three 50-ml
conicals, diluted in phosphate-buffered saline (PBS), and collected by centrifu-
gation. The remaining methylcellulose was removed by two subsequent PBS
washes in 50- and 15-ml conicals with centrifugation. To lyse the cells for analysis,
cell pellets were resuspended in Nonidet P-40 (NP-40) lysis buffer (50 mM
Tris-HCl, 150 mM NaCl, 2 mM EDTA, 10% glycerol, 1% NP-40, 0.4 mM
phenylmethylsulfonyl fluoride [PMSF], 1 mM sodium vanadate [Na3VO4], pro-
tease and phosphatase inhibitor cocktails [Sigma] at 1:100). Cell pellets with lysis
buffer were incubated on ice for 10 min with occasional vortexing and then
clarified by high-speed centrifugation. To harvest the controls in K-SFM without
methylcellulose, cells were washed two times in cold PBS on ice and scraped into
NP-40 lysis buffer on ice. After a 10-min incubation on ice, cells were clarified by
centrifugation as described above.
Western blot analysis. Protein concentrations of lysates were determined by
the Bio-Rad DC protein assay system (Bio-Rad, Hercules, Calif.). Equal
amounts of lysates were suspended in 3 sodium dodecyl sulfate sample buffer,
boiled for 5 min, and electrophoresed on a sodium dodecyl sulfate–7.5% poly-
acrylamide gel. Proteins were transferred to an Optitran nitrocellulose mem-
brane (Schleicher & Schuell Bioscience, Keene, N.H.) in a Bio-Rad transfer unit,
and Western blot analyses were performed. After blocking in 5% milk in Tris-
buffered saline–Tween 20 (TBST), the membranes were incubated overnight in
primary antibody on a nutator at 4°C. The antibodies used included anti-involu-
crin (1:1,000; Sigma), antiactin (1:200), anti-GRP78 (1:200), anti-HA (1:200),
and anti-green fluorescent protein (GFP; 1:200) from Santa Cruz Biotechnolo-
gies (Santa Cruz, Calif.), anti-phospho Akt (Ser473; 1:500) and anti-Akt (1:500)
from Cell Signaling Technology (Beverly, Mass.), and anti--catenin (1:500)
from BD Transduction Laboratories (San Jose, Calif.). After three 5-min washes
in TBST, the membranes were incubated in horseradish peroxidase-tagged sec-
ondary antibodies (1:1,000; Amersham Biosciences, Piscataway, N.J., and Dako,
Carpinteria, Calif.) at room temperature for 1 h on a nutator. After three 5-min
washes in TBST, antibody-bound proteins were detected via autoradiography
with the Pierce SuperSignal West Pico System (Pierce, Rockford, Ill.). Densi-
tometry was performed with the Image J software (National Institutes of
Health).
Transfections and plasmids. The plasmids used for transient transfection
assays included pSG5, pSG5-LMP2A, pSG5-LMP2A PY (gift from M. Ikeda
and R. Longnecker) (13), pSG5-LMP2A ITAM, XE69 encoding GFP–-cate-
nin (gift from R. Moon), pCMV6-myrAkt, pBabe-PI3K CAAX, and pBabe-PI3K
K227E (gifts from C. Der). Transfections were performed with FuGENE 6
(Roche, Basel, Switzerland) in accordance with the manufacturer’s directions.
Cell fractionations. Cellular fractionations were performed with Optiprep
(Sigma), as adapted from the manufacturer’s protocol. Briefly, cells were resus-
pended in cold buffer A (20 mM HEPES, 10 mM KCl, 0.1 mM EDTA, 0.1 mM
EGTA, 1 mM dithiothreitol, 0.5 mM PMSF, 1 mM Na3VO4, protease and
phosphatase inhibitor cocktails at 1:100), incubated on ice for 15 min, and
vortexed for 1 min in the presence of 1% NP-40. Crude nuclei were pelleted at
low speed, and cytosolic extracts (supernatants) were collected. Nuclei were
washed in homogenization medium (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2,
20 mM Tris [pH 7.8]) and purified over an Optiprep gradient with 25, 30, and
35% layers. Banded nuclei were collected and lysed in NE buffer (20 mM
Tris-HCl, 1.5 mM MgCl2, 0.2 mM EDTA, 25% glycerol, 0.5 mM PMSF, 1 mM
Na3VO4, protease and phosphatase inhibitor cocktails at 1:100) with 400 mM
NaCl. After incubation on ice for 10 min with occasional vortexing, nuclear
extracts were clarified via high-speed centrifugation.
RESULTS
Epithelial cell differentiation is inhibited in LMP2A-ex-
pressing HFK cells. LMP2A has been shown to have onco-
genic capacity when expressed in HaCaT keratinocytes as
LMP2A-expressing HaCaT cells were capable of anchorage-
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independent growth in soft agar and gave rise to aggressive,
poorly differentiated tumors when injected into immunodefi-
cient mice (28). Furthermore, differentiation was inhibited
when cells were grown in organotypic raft cultures, and expres-
sion of the differentiation marker involucrin was decreased
(28). To determine if LMP2A expression similarly affects the
normal epithelial cell line derived from HFK cells, stable HFK
cell lines expressing LMP2A were established. LMP2A expres-
sion in HFK cells did not confer anchorage-independent
growth or tumor formation in nude mice (data not shown).
To investigate whether LMP2A affects epithelial cell differ-
entiation, HFK cells stably expressing either the vector or
LMP2A were induced to differentiate in semisolid methylcel-
lulose medium and assessed for involucrin expression. Involu-
crin expression was significantly lower in LMP2A-expressing
HFK cells than in the vector control cell line when cells were
grown in K-SFM (Fig. 1A). During growth in methylcellulose,
involucrin expression greatly increased in the vector control
cells and this increase was blocked in LMP2A-expressing cells.
These findings indicate that LMP2A decreases steady-state
levels of involucrin and inhibits differentiation-induced expres-
sion of involucrin.
Two motifs in the LMP2A N-terminal signaling arm are
important for various aspects of the signaling capacity of
LMP2A. The ITAM of LMP2A is required for its ability to
block B-cell receptor signaling and to activate PI3K/Akt sig-
naling in B cells. The PY motifs of LMP2A mediate interaction
with members of the Nedd4 family of ubiquitin ligases, and
these motifs affect the turnover of LMP2A and associated
kinases, such as Lyn, in B cells. To ascertain the importance of
the ITAM and PY motifs to LMP2A signaling and effects on
epithelial differentiation, stable cell lines expressing mutant
FIG. 1. The PY motif of LMP2A is important for inhibition of involucrin expression. (A) HFK cells (4  106) stably expressing the pBabe
vector, LMP2A, LMP2A ITAM, and LMP2A PY were resuspended in K-SFM-methylcellulose medium. An equal number of cells were plated
in parallel in tissue culture plates with K-SFM. Cells were harvested after 28 and 54 h, and immunoblot analyses were performed. Induction of
differentiation was assessed with antibodies against involucrin, and expression of the LMP2A constructs was determined via anti-HA immuno-
blotting. Antiactin was included as a loading control. (B and C) Densitometry was performed, and involucrin levels at 28 h were normalized to the
corresponding actin levels (B) or to expression of LMP2A (C) and graphed.
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LMP2A protein with either the ITAM deleted (LMP2A
ITAM) or mutated PY motifs (LMP2A PY) were estab-
lished. Decreased amounts of involucrin were detected in cells
expressing LMP2A or the ITAM and PY mutant proteins in
K-SFM with a slightly increased amount in the cells expressing
the two mutant proteins (Fig. 1A). Involucrin expression sig-
nificantly increased in the vector control cells when they were
grown in methylcellulose but did not increase in cells express-
ing either LMP2A or the LMP2A ITAM mutant protein at
28 h. In contrast, involucrin expression was induced in cells
expressing the PY mutant protein, although the level of induc-
tion was reduced compared to that obtained with the vector.
For comparison, the involucrin levels were normalized to
actin (Fig. 1B). After differentiation induction in methylcellu-
lose, involucrin expression in the PY mutant was approxi-
mately half the level in the vector control. In the wild-type and
ITAM mutant LMP2A-expressing cells, involucrin levels re-
mained low at approximately 1/10 of the level in the vector
controls (Fig. 1B). Expression of involucrin in all groups grown
in methylcellulose increased further by the 54-h time point. As
LMP2A and the mutant proteins were expressed at slightly
different levels, the amount of involucrin was normalized to
LMP2A expression (Fig. 1C). After 28 h in methylcellulose,
the amount of involucrin was unchanged in the LMP2A or the
ITAM mutant protein-expressing cells relative to that in their
counterparts in K-SFM, and involucrin levels were 10-fold
higher in the cells expressing the PY mutant protein compared
to those in the wild-type and ITAM mutant protein-expressing
cells. These data indicate that the inhibition of involucrin in-
duction by growth in methylcellulose is impaired by loss of the
PY motifs while deletion of the ITAM only slightly affected the
ability of LMP2A to block differentiation. Therefore, the PY
motifs are essential for LMP2A-mediated inhibition of epithe-
lial cell differentiation.
The ITAM of LMP2A is required for LMP2A-mediated Akt
activation in HFK cells. LMP2A has been previously shown to
activate Akt in epithelial cells (23, 28). In B cells, LMP2A-
mediated activation of Akt occurs via PI3K signaling initiated
through the LMP2A ITAM (31). To identify the domains of
LMP2A that are responsible for PI3K/Akt activation in epi-
thelial cells, immunoblot analysis of HFK cells stably express-
ing the vector, LMP2A, LMP2A ITAM, and LMP2A PY
was performed with an antibody specific for the phosphory-
lated, activated form of Akt. Phosphorylated Akt was readily
detected in HFK cells expressing LMP2A and the PY mutant
but was barely detectable in cells expressing the vector control
or the ITAM mutant protein (Fig. 2A). The levels of phos-
phorylated Akt were normalized to the amounts of actin (Fig.
2B) and to the levels of LMP2A and the mutant proteins (Fig.
2C). These data revealed that activation of Akt was equivalent
for LMP2A and the PY mutant protein but was lost in the
ITAM mutant protein. Thus, the activation of PI3K and its
downstream effector Akt by LMP2A in epithelial cells requires
the LMP2A ITAM but not the PY motifs.
The ITAM and PY motifs both contribute to LMP2A-medi-
ated effects on -catenin in HFK cells. LMP2A has recently
been shown to activate the -catenin pathway in HFK cells, in
part via effects on PI3K signaling (23). As the ITAM of
LMP2A is required for PI3K/Akt activation in B cells and now
in epithelial cells, the contribution of the ITAM and the PY
motifs to LMP2A-mediated effects on -catenin was investi-
gated. HFK cells were cotransfected with GFP–-catenin in
combination with the vector, LMP2A, LMP2A ITAM, or
LMP2A PY and fractionated into cytosolic and nuclear com-
ponents, and levels of GFP–-catenin and endogenous -cate-
nin were determined by immunoblotting. Increased levels of
GFP–-catenin were detected in the cytosol of LMP2A-tran-
fected cells relative to those in the vector control (Fig. 3A).
Normalizing the amounts of GFP–-catenin to LMP2A ex-
pression revealed that loss of the ITAM domain did not affect
the ability of LMP2A to stabilize GFP–-catenin in the cytosol
(Fig. 3A). This finding concurs with previous work that showed
that inhibition of PI3K did not affect the LMP2A-mediated
increase in cytosolic GFP–-catenin. Importantly, the PY mu-
tant protein was completely unable to stabilize cotransfected
GFP–-catenin, indicating that this property of LMP2A was
dependent on its PY motifs and their putative interactions with
ubiquitin ligases.
The transfected GFP–-catenin was not detectable in the
nucleus; therefore, the effects of LMP2A and domain mutant
proteins were determined by assessing the levels of endoge-
nous -catenin. Consistent with our previously published data,
LMP2A expression led to an increase in nuclear levels of
FIG. 2. The ITAM is required for LMP2A-mediated Akt activa-
tion. (A) HFK cells stably expressing the pBabe vector, LMP2A,
LMP2A ITAM, and LMP2A PY were harvested at confluency after
48 h of starvation (i.e., with BPE and EGF supplements withheld).
Activated Akt was detected by immunoblotting for activated phospho-
Akt (P-Akt) in comparison with levels of total Akt. Expression levels of
wild-type and mutant LMP2A were determined via anti-HA immuno-
blotting. Antiactin was included to control for protein loading. (B and
C) Densitometry was performed, and phospho-Akt levels were nor-
malized to the corresponding actin levels (B) or to expression of
LMP2A (C) and graphed.
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-catenin compared to the vector control (Fig. 3B) (23). This
accumulation was less dramatic with the ITAM mutant pro-
tein, consistent with our previously identified role for PI3K
signaling in LMP2A-mediated nuclear -catenin accumula-
tion. Nuclear -catenin levels in cells expressing LMP2A PY
were comparable to the levels detected in vector control-trans-
fected cells (Fig. 4B). This is consistent with the lower levels of
cytosolic -catenin observed in cells expressing the PY mutant
protein and suggests that the low levels of cytoplasmic -cate-
nin result in decreased nuclear -catenin (Fig. 3A and 4A).
Normalization of nuclear -catenin to LMP2A expression con-
firmed that both domains contributed to the higher levels of
nuclear -catenin (Fig. 3B).
PI3K and Akt activation contributes to stabilization of cy-
toplasmic GFP–-catenin. To further investigate the role of
the ITAM and PY motifs and activation of PI3K and Akt on
the effects of LMP2A on -catenin, cells were transfected with
the vector, LMP2A, or the PY mutant protein and treated with
the PI3K-specific inhibitor LY, an Akt inhibitor, or the vehicle
control (DMSO) and fractionated to assess -catenin levels in
the cytosol. The amount of GFP–-catenin was increased in
the cytosol of LMP2A-expressing cells compared to that in the
vector control and was not increased in cells expressing the PY
mutant protein (Fig. 4A). Normalization of GFP–-catenin
expression to LMP2A levels confirmed the requirement for the
PY motif in the stabilization of -catenin (Fig. 3A and 4B).
Inhibition of PI3K or Akt did not affect the levels of -catenin
in the vector control cells; however, this inhibition further
decreased the -catenin level in the LMP2A PY mutant cells
to less than that in the vector control cells (Fig. 4A). These
data indicate that activation of PI3K and Akt by LMP2A gov-
erns the steady-state levels of -catenin in LMP2A-expressing
cells and that the PY motifs of LMP2A are required for the
accumulation of elevated levels of -catenin.
PI3K induces -catenin stabilization. These data implicate
both the PY motifs and the ITAM of LMP2A in its effects on
-catenin. The ITAM is responsible for activation of PI3K/Akt
signaling by LMP2A, and LY-mediated inhibition of effects on
FIG. 3. The ITAM and PY motifs contribute to the effects of LMP2A on -catenin stabilization and nuclear translocation. HFK cells were
cotransfected with GFP–-catenin in combination with pSG5, pSG5-LMP2A, pSG5-LMP2A ITAM, or pSG5-LMP2A PY. Supplements were
withheld for 24 h prior to harvesting. Upon harvesting, cells were fractionated into their cytosolic (A) and nuclear (B) compartments and analyzed
by immunoblotting. (A, top) Anti-GFP immunoblotting determined levels of GFP–-catenin in the cytosols of transfected cells, and anti-HA
detected expression of the LMP2A constructs. Antiactin and anti-GRP78 blot assays were included to assess protein loading and the integrity of
the fractionation procedure, respectively. (A, bottom) Densitometry was performed, and GFP–-catenin levels were normalized to the expression
of LMP2A and graphed. (B, top) Nuclear -catenin was detected with antibodies against -catenin, and LMP2A expression was determined with
anti-HA antibodies. GRP78 is an endoplasmic reticulum marker, and anti-GRP78 immunoblotting indicated the purity of the nuclear extracts. An
antiactin immunoblot served as a protein loading control. (B, bottom) Densitometry was performed, and -catenin levels were normalized to the
expression of LMP2A and graphed. Vec, vector; exp, exposure.
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-catenin indicates that the PI3K pathway also contributes to
-catenin accumulation and nuclear translocation in LMP2A-
expressing cells. To further ascertain the role of PI3K and Akt
in this process, HFK cells were transiently transfected with two
forms of constitutively active PI3K and a constitutively acti-
vated form of Akt. PI3K-CAAX is targeted to the membrane
via farnesylation, where it leads to activation of downstream
kinases that can activate Akt. PI3K K227E has a mutation in its
Ras interaction domain that mimics Ras-mediated activation
of PI3K. Myristylated Akt (myr-Akt) is also targeted to the
membrane, resulting in constitutively activated, membrane-
bound Akt. These constructs were cotransfected with GFP–-
catenin, the cells were fractionated, and effects on GFP–-
catenin levels were determined by immunoblot analysis and
compared with vector and LMP2A cotransfections. Expression
of both constitutively active PI3K constructs dramatically in-
creased the cytosolic levels of GFP–-catenin and exceeded
the levels in LMP2A-expressing cells (Fig. 5). These data in-
dicate that PI3K activation affects -catenin stabilization in
these cells. Interestingly, myr-Akt did not affect GFP–-cate-
nin levels (Fig. 5). These data may indicate that some other
PI3K effector is responsible for -catenin signaling effects.
However, the inhibition of GFP–-catenin accumulation by
the Akt inhibitor (Fig. 4) suggests that Akt activity is required.
These findings suggest that the localization of Akt is a critical
factor and that membrane-bound Akt cannot affect -catenin
levels. Treatment with LY, which inhibits the kinase domain of
PI3K, blocked cytosolic GFP–-catenin accumulation in cells
cotransfected with either LMP2A or PI3K K227E but not with
PI3K CAAX (Fig. 5, right panel). These data indicate that
PI3K activation and signaling via the LMP2A ITAM contrib-
ute to the accumulation of -catenin.
DISCUSSION
This study reveals that LMP2A expression in telomerase-
immortalized, normal HFK cells inhibited epithelial cell dif-
ferentiation in semisolid methylcellulose-based differentiation
assays. The ITAM and PY motifs in the cytoplasmic, N-termi-
nal signaling arm of LMP2A contributed to the observed in-
hibition of differentiation, with a more prominent role for the
PY motifs, as their deletion led to an inefficient block of in-
volucrin expression (Fig. 1). The PY motifs were also found to
significantly contribute to another pathway activated by
LMP2A in epithelial cells, the -catenin pathway. In cells ex-
pressing the LMP2A PY mutant protein, the levels of both
cytosolic and nuclear -catenin were decreased relative to
those in wild-type LMP2A-expressing cells (Fig. 3 and 4). The
ITAM of LMP2A was responsible for activation of PI3K and
Akt (Fig. 2) and also contributed to LMP2A-mediated effects
on -catenin, as its deletion was associated with decreased
levels of nuclear -catenin relative to wild-type LMP2A (Fig.
3).
In contrast to previous data detailing the oncogenic capacity
of LMP2A in the keratinocyte cell line HaCaT (28), LMP2A
was unable to transform the normal HFK cell line. LMP2A-
expressing HFK cells were incapable of colony formation in
soft agar and did not induce tumor formation in nude mice
(data not shown). However, the data presented in this report
imply that although LMP2A is not oncogenic outright, it does
FIG. 4. PI3K and Akt activation regulates basal levels of -catenin
in LMP2A-expressing cells. (A) HFK cells were transfected with pSG5,
pSG5-LMP2A, and pSG5-LMP2A PY. EGF and BPE supplements
were withheld for 48 h, and the cells were treated with 25 M LY, 10
M Akt inhibitor, or a DMSO control for 24 h prior to being har-
vested. At 48 h after transfection, cells were harvested, fractionated to
isolate the cytosol, and subjected to immunoblot analysis to determine
cytosolic -catenin levels (top). Anti-HA immunoblotting revealed
levels of the transfected LMP2A constructs (middle), and antiactin and
anti-GRP78 (an endoplasmic reticulum chaperone) were included as
loading controls (bottom). (B) Densitometry was performed, and
GFP–-catenin levels were normalized to the expression of LMP2A
and graphed. Vec, vector; Inhib, inhibitor.
FIG. 5. Constitutively active PI3K, but not myr-Akt, stabilizes cy-
toplasmic -catenin. HFK cells were cotransfected with GFP–-cate-
nin in combination with vector (Vec), LMP2A, myr-Akt, PI3K CAAX,
and PI3K K227E. Supplements were withheld, and cells were treated
with DMSO or 25 M LY for 24 h prior to being harvested. Cells were
analyzed by immunoblotting with anti-GFP antibodies to detect levels
of GFP–-catenin in the cytosol. Anti-GRP78 immunoblotting re-
vealed equal loading of cytosolic proteins.
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alter properties of the cell such that in certain contexts, it may
confer a selective growth advantage. As shown here and in
previous studies, LMP2A blocks epithelial cell differentiation,
activates PI3K/Akt signaling, and activates the -catenin path-
way (23, 28). These properties could poise the cells at the
threshold of transformation such that in combination with
other viral proteins or genetic mutations, LMP2A might en-
courage or enable oncogenesis to proceed. This may, in part,
explain why LMP2A conferred oncogenic properties on the
HaCaT cell line (28). HaCaT cells were spontaneously immor-
talized, are aneuploid, and have collected a variety of genetic
aberrations over time such as mutation and inactivation of the
tumor suppressor p53 (1, 2, 17). Expression of LMP2A might
have served as the catalyst needed to transform the HaCaT
cells. In relatively normal HFK cells, the threshold for trans-
formation is likely higher than that in HaCaT cells, and addi-
tional genetic alterations or expression of other viral proteins
are required for oncogenesis. These data support a contribu-
tory role for LMP2A in the genesis of EBV-associated malig-
nancies, with coexpression of other viral proteins and perhaps
in the context of altered cellular milieus.
The present study reveals an important role for the PY
motifs of LMP2A in its effects on epithelial cell differentiation
and -catenin signaling. Mutation of the PY motifs blocked the
ability of LMP2A to increase cytosolic -catenin levels with
subsequent decreased nuclear translocation (Fig. 3 and 4).
Furthermore, the PY motifs contributed to the inhibition by
LMP2A on induction of involucrin expression in a methylcel-
lulose-based differentiation assay (Fig. 1). The PY motifs me-
diate interaction with the WW domain-containing ubiquitin
ligases that make up the Nedd4 family (13). In B cells, inter-
action of LMP2A with members of the Nedd4 ubiquitin ligase
family enables it to increase turnover of proteins such as Lyn
kinase associated with BCR signaling via ubiquitination and
degradation (13, 14, 35). This contributes to LMP2A-mediated
silencing of BCR activation and signaling to enable mainte-
nance of viral latency. Members of the Nedd4 family are also
expressed in epithelial cells, and it is likely that a similar in-
teraction occurs in epithelial cells (15, 30). As some BCR-
associated kinases such as Lyn are not ubiquitously expressed
in epithelial cells, the substrates of this interaction are proba-
bly different, resulting in distinct consequences. The fact that
LMP2A-mediated effects on epithelial differentiation and
-catenin signaling were affected by mutation of the PY motifs
indicates that interactions between ubiquitin ligases and
LMP2A are a major contributing factor to the effects of
LMP2A on epithelial cell growth and signaling. It will be im-
portant to further characterize these putative interactions and
target substrates in LMP2A-expressing epithelial cells.
In addition to the PY motifs, the data presented here also
implicate the ITAM in LMP2A signaling effects in epithelial
cells. It has been established previously that the ITAM is re-
quired for the ability of LMP2A to activate PI3K and Akt
signaling in B cells (31). The present study establishes that the
ITAM is also required for LMP2A-mediated Akt activation in
epithelial cells (Fig. 3). Furthermore, the ITAM of LMP2A
contributes to its effects on the nuclear accumulation of -cate-
nin (Fig. 4). This is consistent with our previously published
finding that activation of the PI3K pathway is required for
LMP2A-mediated nuclear accumulation of -catenin, the hall-
mark of -catenin pathway activation. In further support of a
prominent role for LMP2A-mediated activation of PI3K in
-catenin signaling, constitutively active PI3K constructs were
able to recapitulate the -catenin accumulation previously ob-
served in LMP2A-expressing HFK cells. Interestingly, how-
ever, the constitutively active myr-Akt construct was unable to
affect cytosolic or nuclear levels of -catenin. This may indicate
that a PI3K effector other than Akt is involved in -catenin
accumulation and nuclear translocation. Alternatively, Akt is
involved, but myr-Akt, although constitutively active, is unable
to translocate to parts of the cell required to execute its effects
on -catenin signaling because it is trapped at the plasma
membrane via its myristylation moiety.
In summary, these data reveal important effects of LMP2A
on differentiation and signaling pathways in epithelial cells.
The ITAM of LMP2A is important for -catenin nuclear trans-
location and accumulation, and these findings implicate the
PI3K signaling pathway in the mechanism of these effects.
Importantly, the PY motifs are required for the ability of
LMP2A to inhibit HFK cell differentiation and are essential
for its effects on -catenin. These data suggest that differenti-
ation is inversely correlated with -catenin activation and that
LMP2A effects on ubiquitin ligases are a major factor in
LMP2A signaling and its effects on epithelial growth regula-
tion.
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